Introduction: We aimed to evaluate the cost-effectiveness/cost-savings of point-of-care anorectal function testing with an investigational device (RED) to triage therapy for chronic constipation in general gastroenterology.
Methods: A Markov model was constructed to evaluate cost-effectiveness/cost-savings over a 1-year time horizon comparing empiric drug/pelvic floor physical therapy to testing guided care.
Results: RED appears to inform the cost-effective strategy for chronic constipation. Compared with usual care without RED, it reduces insurer costs by $810 and patient costs by $6,903.
Discussion: Point-of-care testing using RED appears cost-effective/cost-saving to triage chronic constipation care in general gastroenterology.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11617264 | PMC |
http://dx.doi.org/10.14309/ajg.0000000000002989 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!